At Yellowbrick, because our patients have complex psychiatric and neurobehavioral symptoms, our clinician’s use extensive neuropsychological testing of cognitive functioning and state-of-the-art diagnostics to identify biological substrates that affect our patients’ external and internal processes.
Electrophysiological assessment: These quantitative electroencephalogram (EEG) neuropsychological tests are used to map our patients’ electrophysiological brain patterns. During assessment, we ask patients to take cognitive and emotional evaluations that show how the patient’s brain responds to changing external and internal demands. In addition to monitoring brain activity during different cognitive and emotional tasks, we also evaluate the interaction between the brain and the peripheral nervous system with an electrophysiological assessment that measures the interval between heartbeats and physiological and emotional arousal. These data allows us to understand the relationship between the patient’s cognition and emotions.
Multimodality imaging: Where the patient’s history and assessment call into question the integrity between brain structure and subcortical brain function, Yellowbrick uses high-resolution structural Magnetic Resonance Imaging (MRI) protocols. In addition, we simultaneously correlate metabolic activity with quantitative electrophysiology using positron emission tomography (PET). Using PET, nuclear medicine helps us visualize subcortical brain structure activity and find detailed explanations for the patient’s quantitative EEG and neurobehavioral findings.
Assessment of the cognitive functions: In addition to assessing brain activity, Yellowbrick evaluates the patient’s cognitive performance with tools that probe well-defined cognitive domains such as attention, working memory, delayed memory, problem-solving, and visual/spatial processing and memory. These tools study new information acquisition and manipulation, thinking flexibility, and simple reaction times to determine the relationships between sensory input and motor response. These data allow us to identify a patient’s strengths and weaknesses and develop patient-specific therapeutic interventions
Assessment of the emotional system: A patient’s cognitive performance is often influenced by their emotions, and emotions affect anxiety levels, which in turn impact one’s engagement in effective cognitive processes and directed activities. To assess emotional deregulation levels, we use affective Go/No-Go and self-report tests that measure the emotional integrity of the brain’s limbic system. Lastly, after the assessment, we integrate the data into a comprehensive report to elucidate the patient’s strengths and weaknesses, develop directed therapies, and then later, re-evaluate the effectiveness of the treatment.
At Yellowbrick, emerging adults find their way home.
For more information, please contact Yellowbrick at 866.364.2300.